Tecan

3Q26 Trading Update: Outlook raised on improving demand

05/11/26 -"The strong 3Q print, combined with a positive FX effect, leads us to raise our 2026 sales estimate by c. 1.9%, which feeds through to our 2027 (c. +2.2%) and 2028 (c. +2.3%) estimates. We also raise ..."

PDF page sample
Pages
68
Language
English
Published on
05/11/26
Download
You may also be interested by these reports :
05/11/26
Tecan’s 3Q sales growth accelerated to 6.9% (LC), well above the 3.4% run rate of 1H26, with both segments contributing to the performance. ...
05/11/26
The strong 3Q print, combined with a positive FX effect, leads us to raise our 2026 sales estimate by c. 1.9%, which feeds through to our 2027 (c. ...
05/11/26
GN’s Q3 sales met market expectations, while profitability exceeded expectations, largely driven by tariff refunds. 2026 guidance was unchanged. ...
04/11/26
Following preliminary figures reported last month, Demant has released its Q3 report. As announced in Q3, hearing aids benefited from strong initial ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO